To identify the potential roles of complement activation products in the production of inflammatory cytokines in mice challenged with LPS/D-GalN, we investigated the effect of C3aR or C5aR blockage respectively on LPS/D-GalN-induced liver inflammation. The gene discussed is GAL; the disease is Hepatitis.